Dabomb Protein
DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more
Market Cap & Net Worth: Dabomb Protein (6578)
Dabomb Protein (TWO:6578) has a market capitalization of $39.47 Million (NT$1.31 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #25550 globally and #1595 in its home market, demonstrating a 3.12% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dabomb Protein's stock price NT$18.15 by its total outstanding shares 71942000 (71.94 Million).
Dabomb Protein Market Cap History: 2016 to 2026
Dabomb Protein's market capitalization history from 2016 to 2026. Data shows change from $49.32 Million to $39.47 Million (-3.29% CAGR).
Dabomb Protein Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dabomb Protein's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.13x
Dabomb Protein's market cap is 0.13 times its annual revenue
0.14x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.70x
Dabomb Protein's market cap is 3.70 times its annual earnings
5.50x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $49.32 Million | $726.76 Million | $68.31 Million | 0.07x | 0.72x |
| 2017 | $47.53 Million | $562.38 Million | $28.02 Million | 0.08x | 1.70x |
| 2018 | $38.98 Million | $622.85 Million | $25.14 Million | 0.06x | 1.55x |
| 2019 | $42.51 Million | $646.60 Million | $21.19 Million | 0.07x | 2.01x |
| 2020 | $38.36 Million | $605.22 Million | $7.19 Million | 0.06x | 5.33x |
| 2021 | $35.77 Million | $470.63 Million | -$62.45 Million | 0.08x | N/A |
| 2022 | $33.00 Million | $433.63 Million | -$44.66 Million | 0.08x | N/A |
| 2023 | $44.60 Million | $384.41 Million | -$57.02 Million | 0.12x | N/A |
| 2024 | $43.05 Million | $337.82 Million | $11.64 Million | 0.13x | 3.70x |
Competitor Companies of 6578 by Market Capitalization
Companies near Dabomb Protein in the global market cap rankings as of March 19, 2026.
Key companies related to Dabomb Protein by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Dabomb Protein Historical Marketcap From 2016 to 2026
Between 2016 and today, Dabomb Protein's market cap moved from $49.32 Million to $ 39.47 Million, with a yearly change of -3.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$39.47 Million | -4.97% |
| 2025 | NT$41.53 Million | -3.54% |
| 2024 | NT$43.05 Million | -3.47% |
| 2023 | NT$44.60 Million | +35.16% |
| 2022 | NT$33.00 Million | -7.74% |
| 2021 | NT$35.77 Million | -6.77% |
| 2020 | NT$38.36 Million | -9.75% |
| 2019 | NT$42.51 Million | +9.04% |
| 2018 | NT$38.98 Million | -17.98% |
| 2017 | NT$47.53 Million | -3.63% |
| 2016 | NT$49.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Dabomb Protein was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.47 Million USD |
| MoneyControl | $39.47 Million USD |
| MarketWatch | $39.47 Million USD |
| marketcap.company | $39.47 Million USD |
| Reuters | $39.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.